A research agenda for non-communicable disease prevention and control in India.

A research agenda for non-communicable disease prevention and control in India.
复制标题

DOI:
10.1186/s12961-020-00639-0
复制
发表时间:
2020-10-30
影响因子:
4
通讯作者:
Squiers L
Squiers L
中科院分区:
医学2区
文献类型:
--
作者:
Kataria I;Siddiqui M;Gillespie T;Goodman M;Dhillon PK;Bann C;Squiers L

文献摘要

参考文献

被引文献

相似文献

非传染性疾病占印度总死亡人数的62%;令人关切的是可预防的过早死亡,占死亡率的48%。这项研究的目的是建立一个共识的研究议程,非传染性疾病的预防和控制,有可能影响政策,计划和医疗保健提供在印度。为了制定一个非传染性疾病研究议程,我们与社区合作委员会和科学咨询小组进行了三步进程,包括两次网络调查和一次面对面会议。首先,采用德尔菲法生成主题。第二,这些想法在面对面的会议上进行了审议,导致23个研究问题的优先级,这些问题由利益相关者使用雪卡方法与科学咨询小组和社区合作委员会进行优势,弱点,机会和威胁分析。这一步骤导致确定了15个低努力,高影响力的优先研究问题的各种健康结果跨研究学科的基础上与较大的群体达成共识的讨论。最后,第二次网上调查的结果是,所有利益攸关方利用线性混合效应回归模型确定了15个最重要的关键优先研究问题。最后一组15个优先研究问题侧重于个人、社区、系统和政策层面的干预措施。研究问题的重点是确定加强保健系统和保健服务的干预措施,包括护理模式和改善非传染性疾病筛查、诊断和治疗的机会,确定政府政策的影响,评估预防方案(如烟草、环境改善)的有效性,并测试在人口一级监测非传染性疾病的研究工具和资源。为在印度选择和实施非传染性疾病方案和政策提供证据基础,需要进行投资。这些投资应遵循印度预防和控制非传染性疾病的国家研究议程。我们的研究结果可以成为印度非传染性疾病国家研究议程的支柱,这些议程可以得到完善,然后由政府机构、私营部门、非政府组织和社区组织采用。
Non-communicable diseases contribute to 62% of total deaths in India; of concern are the preventable premature deaths, which account for a staggering 48% of mortality. The objective of this study was to establish a consensus research agenda for non-communicable disease prevention and control that has the potential to impact polices, programmes and healthcare delivery in India. To develop a non-communicable disease research agenda, we engaged our community collaborative board and scientific advisory group in a three-step process using two web-based surveys and one in-person meeting. First, the Delphi methodology was used to generate topics. Second, these ideas were deliberated upon during the in-person meeting, leading to the prioritisation of 23 research questions, which were subjected to Strength, Weakness, Opportunities and Threat analysis by the stakeholders using the Snow Card methodology with the scientific advisory group and community collaborative board. This step resulted in the identification of 15 low effort, high impact priority research questions for various health outcomes across research disciplines based on discussion with the larger group to reach consensus. Finally, the second web-based survey resulted in the identification of 15 key priority research questions by all stakeholders as being the most important using a linear mixed effect regression model. The final set of 15 priority research questions focused on interventions at the individual, community, systems and policy levels. Research questions focused on identifying interventions that strengthen healthcare systems and healthcare delivery, including models of care and improved access to non-communicable disease screening, diagnosis and treatment, determining the impact of government policies, assessing the effectiveness of prevention programmes (e.g. tobacco, environmental improvements), and testing research tools and resources to monitor non-communicable diseases at the population level. To produce the evidence base for selecting and implementing non-communicable disease programmes and policies in India, investments are needed. These investments should be guided by a national research agenda for the prevention and control of non-communicable diseases in India. Our findings could form the backbone of a national research agenda for non-communicable diseases in India that could be refined and then adopted by government agencies, the private sector, non-governmental and community-based organisations.
DOI: 10.2471/blt.11.091041
发表时间: 2012-01-01
期刊: Bulletin of the World Health Organization: International Journal of Public Health
影响因子: --
作者:
Raban, Magdalena Z;Dandona, Rakhi;Dandona, Lalit
通讯作者: Dandona, Lalit
DOI: 10.22034/apjcp.2017.18.7.2005
发表时间: 2017-07-27
期刊: Asian Pacific journal of cancer prevention : APJCP
影响因子: --
作者:
Nethan, Suzanne;Sinha, Dhirendra;Mehrotra, Ravi
通讯作者: Mehrotra, Ravi
DOI: 10.1353/cpr.2013.0033
发表时间: 2013
期刊: Progress in community health partnerships : research, education, and action
影响因子: --
作者:
Rideout C;Gil R;Browne R;Calhoon C;Rey M;Gourevitch M;Trinh-Shevrin C
通讯作者: Trinh-Shevrin C
DOI: 10.1016/s0140-6736(17)32804-0
发表时间: 2017-12-02
期刊: Lancet (London, England)
影响因子: --
作者:
India State-Level Disease Burden Initiative Collaborators
通讯作者: India State-Level Disease Burden Initiative Collaborators